Anti-Angiogenic Effect of Triptolide in Rheumatoid Arthritis by Targeting Angiogenic Cascade

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Kong, Xiangying ^a   Zhang, Yanqiong ^a   Liu, Chunfang ^a   Guo, Wei ^a   Li, Xiangbin ^a   Su, Xiaohui ^a   Wan, Hongye ^a   Sun, Yanqun ^a   Lin, Na ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; INTERLEUKIN 17; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TRIPTOLIDE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CAPILLARY DENSITY; CELL ADHESION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MECHANISM; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MIGRATION INHIBITION; NONHUMAN; PROTEIN EXPRESSION; RAT; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION;

ANGIOGENESIS MODULATING AGENTS; ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CELL ADHESION; CELL MOVEMENT; CELLS, CULTURED; COLLAGEN; DITERPENES; DRUG COMBINATIONS; EPOXY COMPOUNDS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LAMININ; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; NEOVASCULARIZATION, PATHOLOGIC; PHENANTHRENES; PROTEOGLYCANS; RATS; SYNOVIAL MEMBRANE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84886608491     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077513     Document Type: Article

References (48)

1. Konisti S, Kiriakidis S, Paleolog EM, (2012) Hypoxia-a key regulator of angiogenesis and inflammation in rheumatoid arthritis. Nat Rev Rheumatol. 8: 153-162.
2. Marrelli A, Cipriani P, Liakouli V, Carubbi F, Perricone C, et al. (2011) Angiogenesis in rheumatoid arthritis: a disease specific process or a common response to chronic inflammation? Autoimmun Rev. 10: 595-598.
3. Rothschild BM, Yoon BH, (1982) Thyroid acropachy complicated by lymphatic obstruction. Arthritis Rheum. 25: 588-590.
4. Thairu N, Kiriakidis S, Dawson P, Paleolog E, (2011) Angiogenesis as a therapeutic target in arthritis in 2011: learning the lessons of the colorectal cancer experience. Angiogenesis. 14: 223-234.
5. Hirata S, Matsubara T, Saura R, Tateishi H, Hirohata K, (1989) Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low-dose methotrexate. Arthritis Rheum. 32: 1065-1073.
6. Nagashima M, Wauke K, Hirano D, Ishigami S, Aono H, et al. (2000) Effects of combinations of anti-rheumatic drugs on the production of vascular endothelial growth factor and basic fibroblast growth factor in cultured synoviocytes and patients with rheumatoid arthritis. Rheumatology (Oxford). 39: 1255-1262.
7. Paleolog EM, Young S, Stark AC, McCloskey RV, Feldmann M, et al. (1998) Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis. Arthritis Rheum. 41: 1258-1265.
8. Saeki Y, Matsui T, Saisho K, Tohma S, (2012) Current treatments of rheumatoid arthritis: from the 'NinJa' registry. Expert Rev Clin Immunol. 8: 455-465.
9. Xiao C, Zhou J, He Y, Jia H, Zhao L, et al. (2009) Effects of triptolide from Radix Tripterygium wilfordii (Leigongteng) on cartilage cytokines and transcription factor NF-kappaB: a study on induced arthritis in rats. Chin Med. 4: 13.
10. Wang J, Wang A, Zeng H, Liu L, Jiang W, et al. (2012) Effect of triptolide on T-cell receptor beta variable gene mRNA expression in rats with collagen-induced arthritis. Anat Rec (Hoboken). 295: 922-927.
11. Xue M, Jiang ZZ, Liu JP, Zhang LY, Wang T, et al. (2010) Comparative study on the anti-inflammatory and immune suppressive effect of Wilforlide A. Fitoterapia. 81: 1109-1112.
12. Goldbach-Mansky R, Wilson M, Fleischmann R, Olsen N, Silverfield J, et al. (2009) Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial. Ann Intern Med. 151: 229-40, W49-W51.
13. No authors listed, (2009) Summary for patients: The Chinese herbal remedy Tripterygium wilfordii Hook F in the treatment of rheumatoid arthritis. Ann Intern Med. 151: I-36.
14. Matta R, Wang X, Ge H, Ray W, Nelin LD, et al. (2009) Triptolide induces anti-inflammatory cellular responses. Am J Transl Res. 1: 267-282.
15. Pan XD, Chen XC, (2008) Advances in the study of immunopharmacological effects and mechanisms of extracts of Tripterygium wilfordii Hook. f. in neuroimmunologic disorders. Yao Xue Xue Bao. 43: 1179-1185.
16. Chen ZK, Wang N, Lu HS, (2008) Overexpression of programmed cell death 5 factor enhances triptolides-induced fibroblast-like synoviocytes apoptosis in rheumatoid arthritis. Beijing Da Xue Xue Bao. 40: 567-571.
17. Wang Y, Jia L, Wu CY, (2008) Triptolide inhibits the differentiation of Th17 cells and suppresses collagen-induced arthritis. Scand J Immunol. 68: 383-390.
18. Lu Y, Wang WJ, Leng JH, Cheng LF, Feng L, et al. (2008) Inhibitory effect of triptolide on interleukin-18 and its receptor in rheumatoid arthritis synovial fibroblasts. Inflamm Res. 57: 260-265.
19. Yifan W, Dengming W, Zheng L, Yanping L, Junkan S, (2007) Triptolide inhibits CCR5 expressed in synovial tissue of rat adjuvant-induced arthritis. Pharmacol Rep. 59: 795-799.
20. Lin N, Liu C, Xiao C, Jia H, Imada K, et al. (2007) Triptolide, a diterpenoid triepoxide, suppresses inflammation and cartilage destruction in collagen-induced arthritis mice. Biochem Pharmacol. 73: 136-146.
21. Lin N, Sato T, Ito A, (2001) Triptolide, a novel diterpenoid triepoxide from Tripterygium wilfordii Hook. f., suppresses the production and gene expression of pro-matrix metalloproteinases 1 and 3 and augments those of tissue inhibitors of metalloproteinases 1 and 2 in human synovial fibroblasts. Arthritis Rheum. 44: 2193-2200.
22. Liu C, ZHANG Y, KONG X, ZHU L, PANG J, et al. (2013) Triptolide prevents bone destruction in the collagen-induced arthritis model of rheumatoid arthritis by targeting RANKL/RANK/OPG signal pathway. Evidence-Based Complementary and Alternative Medicine. 2013: 626038.
23. Zhu W, He S, Li Y, Qiu P, Shu M, et al. (2010) Anti-angiogenic activity of triptolide in anaplastic thyroid carcinoma is mediated by targeting vascular endothelial and tumor cells. Vascul Pharmacol. 52: 46-54.
24. Zhu W, Ou Y, Li Y, Xiao R, Shu M, et al. (2009) A small-molecule triptolide suppresses angiogenesis and invasion of human anaplastic thyroid carcinoma cells via down-regulation of the nuclear factor-kappa B pathway. Mol Pharmacol. 75: 812-819.
25. Sun L, Zhang S, Jiang Z, Huang X, Wang T, et al. (2011) Triptolide inhibits COX-2 expression by regulating mRNA stability in TNF-α-treated A549 cells. Biochem Biophys Res Commun. 416: 99-105.
26. Remmers EF, Joe B, Griffiths MM, Dobbins DE, Dracheva SV, et al. (2002) Modulation of multiple experimental arthritis models by collagen-induced arthritis quantitative trait loci isolated in congenic rat lines: different effects of non-major histocompatibility complex quantitative trait loci in males and females. Arthritis Rheum. 46: 2225-2234.
27. Xiao C, Zhao L, Liu Z, Lu C, Zhao N, et al. (2009) The effect of triptolide on CD4+ and CD8+ cells in the Peyer's patch of DA rats with collagen induced arthritis. Nat Prod Res. 23: 1699-1706.
28. Zhang WD, Lu C, Zhao HY, Chen SL, Yang DJ, et al. (2007) Effect of combination glycyrrhiizin and triptolide on TNF-alpha and IL-10 in serum of collagen induced arthritis rats. Zhongguo Zhong Yao Za Zhi. 2007 32: 414-417.
29. Zhang W, Lu C, Liu Z, Yang D, Chen S, et al. (2007) Therapeutic effect of combined triptolide and glycyrrhizin treatment on rats with collagen induced arthritis. Planta Med. 73: 336-340.
30. Gu WZ, Brandwein SR, (1998) Inhibition of type II collagen-induced arthritis in rats by triptolide. Int J Immunopharmacol. 20: 389-400.
31. Brenner M, Meng HC, Yarlett NC, Griffiths MM, Remmers EF, et al. (2005) The non-MHC quantitative trait locus Cia10 contains a major arthritis gene and regulates disease severity, pannus formation and joint damage. Arthritis Rheum. 52: 322-332.
32. Mould AW, Tonks ID, Cahill MM, Pettit AR, Thomas R, et al. (2003) Vegfb Gene Knockout Mice Display Reduced Pathology and Synovial Angiogenesis in Both Antigen-Induced and Collagen-Induced Models of Arthritis. Arthritis Rheum. 48: 2660-2669.
33. Ding Y, Zhao QL, Li YG, Zhang J, Wang QL, et al. (2005) Effects of triptolide on migration of vascular endothelial cells. Sichuan Da Xue Xue Bao Yi Xue Ban. 36: 347-350.
34. Ding Y, Zhang J, Hou L, Zhang J, Wang Q, et al. (2005) Effects of triptolide on anti-angiogenesis by reducing expression of urokinase plasminogen activator. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 22: 778-781.
35. Zhu W, He S, Li Y, Qiu P, Shu M, et al. (2010) Anti-angiogenic activity of triptolide in anaplastic thyroid carcinoma is mediated by targeting vascular endothelial and tumor cells. Vascul Pharmacol. 52: 46-54.
36. Kok TW, Yue PY, Mak NK, Fan TP, Liu L, et al. (2005) The anti-angiogenic effect of sinomenine. Angiogenesis 8: 3-12.
37. He MF, Huang YH, Wu LW, Ge W, Shaw PC, et al. (2010) Triptolide functions as a potent angiogenesis inhibitor. Int J Cancer. 126: 266-278.
38. Yang Y, Liu Z, Tolosa E, Yang J, Li L, (1998) Triptolide induces apoptotic death of T lymphocyte. Immunopharmacology 40: 139-149.
39. Fuchs O, (2010) Transcription factor NF-κB inhibitors as single therapeutic agents or in combination with classical chemotherapeutic agents for the treatment of hematologic malignancies. Curr Mol Pharmacol. 3: 98-122.
40. Li H, Shi X, Liu J, Hu C, Zhang X, et al. (2010) The soluble fragment of VE-cadherin inhibits angiogenesis by reducing endothelial cell proliferation and tube capillary formation. Cancer Gene Ther. 17: 700-707.
41. Ferrara N, Gerber HP, LeCounter J, (2003) The biology of VEGF and its receptors. Nat Med 9: 669-676.
42. Bottomley MJ, Webb NJ, Watson CJ, Holt PJ, Freemont AJ, et al. (1999) Peripheral blood mononuclear cells from patients with rheumatoid arthritis spontaneously secrete vascular endothelial growth factor (VEGF): specific up-regulation by tumour necrosis factor-alpha (TNF-alpha) in synovial fluid. Clin Exp Immunol. 117: 171-176.
43. Pickens SR, Volin MV, Mandelin AM 2nd, Kolls JK, Pope RM, et al. (2010) IL-17 contributes to angiogenesis in rheumatoid arthritis. J Immunol. 184: 3233-3241.
44. Karamysheva AF, (2008) Mechanisms of angiogenesis. Biochemistry (Mosc). 73: 751-762.
45. Hangai M, He S, Hoffmann S, Lim JI, Ryan SJ, et al. (2006) Sequential induction of angiogenic growth factors by TNF-alpha in choroidal endothelial cells. J Neuroimmunol. 171: 45-56.
46. Maruotti N, Cantatore FP, Crivellato E, Vacca A, Ribatti D, (2006) Angiogenesis in rheumatoid arthritis. Histol Histopathol. 21: 557-566.
47. Guadagni F, Ferroni P, Palmirotta R, Portarena I, Formica V, et al. (2007) TNF/VEGF cross-talk in chronic inflammation-related cancer initiation and progression: an early target in anticancer therapeutic strategy. In Vivo. 21: 147-161.
48. Chen YJ, Tsai YM, Kuo CD, Ku KL, Shie HS, et al. (2009) Norcantharidin is a small-molecule synthetic compound with anti-angiogenesis effect. Life Sci. 85: 642-651.